Abstract
Our hypothesis was that the continuation of clopidogrel does not increase the risk of eye hemorrhage, compared to patients not treated with clopidogrel, when a peribulbar anesthesia is required. Our prospective case-control study enrolled two groups of 1,000 patients scheduled for intraocular eye surgery requiring a peribulbar block. Patients treated with clopidogrel were included in group A (1,000 patients). Patients who had never been treated with clopidogrel constituted the control group (group B, 1,000 patients). Hemorrhages were graded as follows: 1 = spot ecchymosis of eyelid and or subconjunctival hemorrhage; 2 = eyelid ecchymosis involving half the lid surface area; 3 = eyelid ecchymosis all around the eye, no increase in intraocular pressure; 4 = retrobulbar hemorrhage with increased intraocular pressure. Grade 1 hemorrhages were observed in 30 patients (3.0 %) in group A and in 20 patients (2.0 %) in group B. No grade 2, 3, or 4 hemorrhage was encountered. There was no significant difference in the grading of hemorrhage between the groups (p = 0.017). Clopidogrel was not associated with a significant increase in potentially sight-threatening local anesthetic complications.
Similar content being viewed by others
References
Michelson AD. Antiplatelet therapies for the treatment of cardiovascular disease. Nat Rev Drug Discov. 2010;9(2):154–69.
Michelson AD. P2Y12 antagonism: promises and challenges. Arterioscler Thromb Vasc Biol. 2008;28(3):s33–8.
Bhatt DL, Fox KA, Hacke WA, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ, CHARISMA Investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354(16):1706–17.
Michelson AD, Frelinger AL, Furman MI. Resistance to antiplatelet drugs. Eur Heart J. 2006;8:G53–8.
Collyer TC, Reynolds HC, Truyens E, Kilshaw L, Corcoran T. Perioperative management of clopidogrel therapy: the effects on in-hospital cardiac morbidity in older patients with hip fractures. Br J Anaesth. 2011;107:911–5.
Hess TM, Liu ES. Clopidogrel therapy in ophthalmic procedures: a survey of subspecialty ophthalmologists and review of current guidelines. Can J Ophthalmol. 2011;46:528–30.
Metzler H, Huber K, Kozek-Langenecker S, Vicenzi MN, Münch A. Coronary stents, dual antiplatelet therapy and peri-operative problems. Anaesthesist. 2007;56:401–10.
Abraham NS, Hlatky MA, Antman EM, Bhatt DL, Bjorkman DJ, Clark CB, Furberg CD, Johnson DA, Kahi CJ, Laine L, Mahaffey KW, Quigley EM, Scheiman J, Sperling LS, ACCF/ACG/AHA. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol. 2010;56:2051–66.
Hamilton RC. Techniques of orbital regional anaesthesia. Br J Anaesth. 1995;75:88–92.
Muraine M, Calenda E, Watt L, Proust N, Cardon A, Eupherte L, Brasseur G. Peribulbar anaesthesia during keratoplasty: a prospective study of 100 cases. Br J Ophthalmol. 1999;83:104–9.
Calenda E, Olle P, Muraine M, Brasseur G. Peribulbar anesthesia and sub-Tenon injection for vitreoretinal surgery: 300 cases. Acta Ophthalmol Scand. 2000;78:196–9.
Dick B, Jacobi FK. Cataract surgery and anticoagulation—current status. Klin Monatsbl Augenheilkd. 1996;209:340–6.
Kallio H, Paloheimo M, Maunuksela EL. Haemorrhage and risk factors associated with retrobulbar/peribulbar block: a prospective study in 1383 patients. Br J Anaesth. 2000;85:708–11.
Benzimra JD, Johnston RL, Jaycock P, Galloway PH, Lambert G, Chung AK, Eke T, Sparrow JM, EPR User Group. The Cataract National Dataset electronic multicentre audit of 55,567 operations: antiplatelet and anticoagulant medications. Eye. 2009;23:6–10.
Mason JO 3rd, Gupta SR, Compton CJ, Frederick PA, Neimkin MG, Hill ML, Heersink MJ, Vail RS, White MF Jr, Feist RM, Thomley ML, Albert MA Jr. Comparison of hemorrhagic complications of warfarin and clopidogrel bisulfate in 25-gauge vitrectomy versus a control group. Ophthalmology. 2011;118:543–7.
Conflict of interest
None of the authors has conflict of interest with the submission.
Informed consent
Approval of our hospital ethics committee was obtained for the prospective case-control study.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Calenda, E., Lamothe, L., Genevois, O. et al. Peribulbar block in patients scheduled for eye procedures and treated with clopidogrel. J Anesth 26, 779–782 (2012). https://doi.org/10.1007/s00540-012-1406-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-012-1406-6